Epigenetic deregulation is intimately associated with the development of human diseases. Intensive studies are currently underway to clarify the mechanism for the sake of achieving ideal diagnostic and therapeutic goals. It has been demonstrated that enzymes with histone-modifying activities can also target non-histone proteins, with the underlying mechanism remaining obscure. In this review, we focus on a novel histone mimicry strategy that may be wildly adapted during the non-histone substrate recognition process. Its potential clinical implications are also discussed.
|Number of pages||6|
|Journal||Frontiers in Biology|
|State||Published - Apr 2013|
Bibliographical noteFunding Information:
editing of this manuscript. This work was supported by grants from NIH (RO1CA125454), Susan G Komen Foundation (KG081310), Mary Kay Ash Foundation (to B.P. Zhou) and pre-doctoral fellowship (BC101068) from DoD Breast Cancer Research Program (to Y. Lin).
- histone mimicry
ASJC Scopus subject areas
- Ecology, Evolution, Behavior and Systematics